CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals Inc. (AMEX: IDP), a biopharmaceutical company focused on developing therapeutics targeting Toll-like Receptors (TLR), today reported financial results for the three and nine months ended September 30, 2006.
